Relay Therapeutics, Inc. Common Stock
$18.84
-$0.13 (-0.69%)
$18.62Day Range$19.22
Key Statistics
Market Cap
$4.16B
Shares Outstanding
219.1M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 16, 2020
Round Lot
100
Locale
US
Trading Data
Day Open
$18.97
Day High
$19.22
Day Low
$18.62
Volume
2.12M
VWAP
$18.88
Prev Close
$18.97
Transactions
--
Acc. Volume
--
About Relay Therapeutics, Inc. Common Stock
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 2836192 employees60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139617-370-8837IPO Jul 16, 2020US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001812364
- Composite FIGI
- BBG00DSS08K9
- Share Class FIGI
- BBG00DSS08L8
- Ticker Root
- RLAY
- SIC Code
- 2836
About Relay Therapeutics, Inc. Common Stock (RLAY) Stock
Relay Therapeutics, Inc. Common Stock (RLAY) closed the 2026-09-16 session at $18.84, down 0.69% versus the previous close (-0.13). The stock opened at $18.97 and traded between $18.62 and $19.22 during that session. Session trading volume was 2.1M shares. The volume-weighted average price (VWAP) is $18.88.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
Relay Therapeutics, Inc. Common Stock has a market capitalization of $4.16 billion. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. RLAY is listed on the XNAS exchange. The company employs approximately 192 people. Relay Therapeutics, Inc. Common Stock is headquartered in CAMBRIDGE, MA. The recorded listing date is 2020-07-16.
On this page you can find market RLAY stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.